Table 3.
Electroanalytical applications of modified PGE.
| Compound | Modifier | Technique | Linear range (μM) | LD (μM) | Sample | Ref. |
|---|---|---|---|---|---|---|
| Acetaminophen | Poly[2,5-di(2-hiophenyl) -1-p-(tolyl)Pyrrole] |
DPV | 0.025–5 | 0.00194 | Pharmaceuticals | [108] |
|
| ||||||
| Acyclovir | ET β-cyclodextrin polymer | SWAdSV | 0.05–0.6 1–9 |
0.00759 | Dosage forms, urine pharmacokinetic studies |
[109] |
|
| ||||||
| 2-Amino-benzimidazole | MI-PPy | DPV | 0.001–30000 | 0.0001 | Biological model samples | [110] |
|
| ||||||
|
γ- Aminobutyric acid |
MI-FUAA/MWCNTs-COOH | DPASV | 0.75–205.19∗ | 0.28∗ | Cerebrospinal fluid, human serum, aqueous | [111] |
|
| ||||||
| Arsenic(V) | PPy-AsO43− | Pot | 50–100000 | 28 | Water | [112] |
|
| ||||||
| Arsenic(III) | Au-NDs/CNTs | ASV | 0.5–80∗ | 0.4 | Tap water | [113] |
|
| ||||||
| Ascorbic acid | MI-PPy | DPV | 250–7000 | 74 | Pharmaceuticals | [114] |
|
| ||||||
| D-, L- Ascorbic acid |
MI-PANI-FSA-C-dots | DPV | 0.006–0.155 0.006–0.165 |
0.000002 0.000001 |
Pharmaceuticals, human plasma | [115] |
|
| ||||||
| D-, L- Aspartic acid |
MI-PI3AA/MWCNTs | DPASV | 0.15–7.4 0.15–8.64 |
0.025 0.016 |
Pharmaceuticals, blood serum | [116] |
|
| ||||||
| D-, L- Aspartic acid |
MI-NAPD/MWCNTs-TiO2-NPs-CHPA | DPASV | 9.98–516.25∗ 9.98–532.72∗ |
1.71∗ 1.76∗ |
Cerebrospinal fluid, blood serum, pharmaceuticals | [117] |
|
| ||||||
| Benzimidazole | MI-PPy | DPV | 3–5000 | 0.7 | Biological | [118] |
|
| ||||||
| Bisphenol A | Au-NPs/PVP | SWAdSV | 0.03–1.1 | 0.001 | Bottled drinking water | [119] |
|
| ||||||
| Bisphenol A | PANI-NRs/MWCNTs | Amp | 1–400 | 0.01 | Spiked boiling water | [120] |
|
| ||||||
| Cadmium | P4VP | Pot | 0.1–100000 | 0.0251 | Environmental, food, biological | [121] |
|
| ||||||
| Cadmium | Poly(4VP-co-Ani) | Pot | 1–10000 | 0.794 | Sea water, tomato, rice, ayurvedic medicine | [122] |
|
| ||||||
| Caffeine | Au-NPs/MIP-sol-gel | SWV | 0.002–0.05 0.05–1.0 |
0.0009 | Urine, plasma, tablets, tea, energy and soda drink | [60] |
|
| ||||||
| Carminic acid | Pd-Au-NPs/PPr | SWV | 0.01–1 | 0.0059 | Popping candy | [123] |
|
| ||||||
| Ceftriaxone sodium | Copper hexacyanoferrate | CV, chrono-amp | 2–72 | 0.54 | Pharmaceuticals | [124] |
|
| ||||||
| Ciprofloxacin | MI-PPy and o-PD | SWV | 0.001–1000 | 0.0000758 | Tablets | [125] |
|
| ||||||
| Chlorogenic acid | MI-PPy | Pot | 1–10000 | 1 | Coffee | [126] |
|
| ||||||
| Chlorpyrifos | MI-PPy | EIS | 20–300∗ | 4.5∗ | Soil | [127] |
|
| ||||||
| Copper | Alga-OMNiIIP | DPASV | 0.008–7.807∗ | 0.0018∗ | Environmental, pharmaceuticals, blood serum | [128] |
|
| ||||||
| Copper | Cu-carmoisine/PANI | Pot | 5–100000 | 2 | Tea leaves, black currants, sour cherry juice | [129] |
|
| ||||||
| Copper | PPy-SSA | Pot | 10–100000 | 5.42 | Electrical copper wire | [130] |
|
| ||||||
| Copper | PPy-P4R | Pot | 10–50000 | 6.7 | Electrical copper wire, tap water | [131] |
|
| ||||||
| Copper | PSS–CnP | DPASV | <1000∗ | 0.00173 | Mineral, river and sea water | [68] |
|
| ||||||
| L-Cysteine | Copper hexa-cyanoferrate NS | chrono-amp | 1–13 | 0.13 | Urine | [132] |
|
| ||||||
| Dextromethorphan | Poly(diallyl-dimethyl-ammonium chloride)/MWCNT/CQDs | DPV | 2–600 | 0.2 | Cough syrups, human urine, plasma | [133] |
|
| ||||||
| Diazepam | ET Bi | DPV | 1.4–16.7 | 1.1 | Tablets, urine | [134] |
|
| ||||||
| Diclofenac sodium | MWCNTs | DPV | 0.047–12.95 | 0.017 | Biological samples, pharmaceuticals | [135] |
|
| ||||||
| 1,4-Dihydroxy-anthraquinone | MI-PPy/MWCNTs-COOH | DPV | 0.01–100 | 0.00415 | Serum, plasma | [136] |
|
| ||||||
| Dipyrone | PPy-dipyrone | Pot | 100–40000 | 86.2 | Spiked human urine, Pharmaceuticals | [62] |
|
| ||||||
| Dopamine | Poly(xylenol orange) | DPV | 2–9 | 0.091 | Injections | [137] |
|
| ||||||
| Dopamine Uric acid |
Poly(amaranth) | DPV | 0–250 0–600 |
0.05 0.2 |
Injections | [138] |
|
| ||||||
| Dopamine Uric acid |
Poly(Naphthol Green B) | DPV | — | — | Injections | [139] |
|
| ||||||
| L-Dopa | Au | DPV | 20–100 | 1.54 | Mucuna pruriens | [140] |
|
| ||||||
| Epinephrine | MI-poly(NHPM-MWCNTs) | DPASV | 0.09–5.90∗ | 0.02∗ | Pharmaceuticals, blood serum | [141] |
|
| ||||||
| Estradiol | Au-NPs/MWCNTs | LSV | 0.07–42 | 0.01 | Blood serum | [142] |
|
| ||||||
| Ferritin | Imprinted Ag@CdS | DPV | 1.99–23.43∗∗ | 0.65∗∗ | Blood serum | [143] |
|
| ||||||
| Fluoxetine | PVC/PEDOT-C14 | ITSV | 0.1–1.0 | 0.035 | Tap and river water | [144] |
| Citalopram | 0.025 | |||||
| Sertraline | 0.045 | |||||
|
| ||||||
| Folic acid | MI-pTAT/sol-gel | DPCSV | 0.007–0.156∗∗ | 0.0021∗∗ | Blood serum, pharmaceuticals | [29] |
|
| ||||||
| Glucose | OxPPyNFs-CoPcTS | DPV | 250–20000 | 100 | Serum samples | [34] |
|
| ||||||
| Glucose | Cu-NPs | Amp | 1–100 100–100000 |
0.44 | Blood serum | [145] |
|
| ||||||
| Glyphosate | MI-pMAC/AuNPs | DPASV | 3.98–176.23∗ | 0.35∗ | Aqueous, soil, human serum |
[146] |
| Glufosinate | 0.54–3.96∗ | 0.19∗ | ||||
|
| ||||||
| Heavy metals | Bi-film | SWASV | 0.01–0.12 | Pb: 0.0024 Cd: 0.0029 Zn: 0.012 |
Simultaneous in situ, aqueous solutions | [64] |
|
| ||||||
| Heavy metals | Nafion-graphene nanocomposite-Bi-film | SWASV | 2–20∗∗ 10–100∗∗ |
Pb: 0.13∗∗ Cd: 0.09∗∗ Zn: 0.17∗∗ |
Tap water | [147] |
|
| ||||||
| Heavy metals | ERGO-Bi-film | SWASV | 2–100∗ | Pb: 0.12∗ Cd: 0.09∗ Zn: 0.19∗ |
Tap water | [28] |
|
| ||||||
| Hemoglobin | MI-pNMGA/QDs-MWCNTs | DPCSV | 27.8–444.0∗ | 6.73∗ | Blood | [148] |
|
| ||||||
| L-Histidine | CIP/MWCNTs | DPASV | 9.990–323.572∗ | 1.980∗ | Pharmaceuticals, blood serum | [67] |
|
| ||||||
| Hydrazine | Au-NPs | SWV Amp |
0.05–1000 25–1000 |
0.042 3.07 |
Drinking water | [32] |
|
| ||||||
| Hydrazine | Cu-NS/MWCNT | SWV Amp |
0.1–800 50–800 |
0.07 4.3 |
River, waste, well waters | [149] |
|
| ||||||
| Hydrochlorothiazide | MI-PPy/MWCNTs-COOH | DPV | 0.0009–10 10–10000 |
0.0001 | Pharmaceuticals, serum | [150] |
|
| ||||||
| Hydrogen peroxide | Ag/FeOOH nanocomposites | Amp | 30–15000 | 22.8 | Disinfectant | [151] |
|
| ||||||
| Hydrogen peroxide | Pd-NPs | Amp | 10–140 | 0.045 | — | [24] |
|
| ||||||
| Hydrogen peroxide | Pt-NPs | Amp | 10–110 | 3.6 | — | [152] |
|
| ||||||
| Insulin | MI-pAEP-MWCNTs | DPASV | 0.000058–0.005647 | 0.0000186 | Pharmaceuticals, blood serum | [65] |
|
| ||||||
| Iodide | PPy-iodide | Pot | 10–100000 | 9.3 | Pharmaceuticals | [153] |
|
| ||||||
| K+, Na+ | PB | CV | 1000–500000 | 600–12000 600–21000 |
Synthetic | [63] |
|
| ||||||
| Lorazepam | MI-PPy/sol-gel/AuNPs | SWV | 0.0002–0.002 0.002–0.020 |
0.00009 | Pharmaceuticals, plasma, urine | [154] |
|
| ||||||
| Lomustine | MF | SWCASV | 0.192–13.6 | 0.0813 | Human blood, urine | [155] |
|
| ||||||
| Magnesium | PPy-Titan yellow | Pot | 10–50000 | 6.28 | Tap and mineral water | [156] |
|
| ||||||
| Mancozeb | SPIONs/MISP | — | 5.96–257.0∗∗ | 0.96∗∗ | Soil, vegetable | [157] |
|
| ||||||
| Methadone | MWCNTs | DPV | 0.1–15 | 0.087 | Human serum, urine | [158] |
|
| ||||||
| D-, L- Methionine | MI-polyBz/MWCNTs-COOH | DPV | 11.7–188.7∗ 11.7–206.3∗ |
3∗ 3∗ |
Pharmaceuticals, blood serum | [159] |
|
| ||||||
| Metoprolol | MI-PPy/MWCNTs-COOH | DPV | 0.06–490 | 0.00288 | Pharmaceuticals, serum | [160] |
|
| ||||||
| Morphine | Au-NPs/MIP/MWCNT | SWV | 0.008–5 | 0.0029 | Human urine, serum | [161] |
|
| ||||||
| Nitrate | PPy-NO3− | Pot | 100–100000 | 50 | Water | [162] |
|
| ||||||
| Nitrite | Polypyronin Y | Amp | 1–100 | 0.5 | Food | [163] |
|
| ||||||
| Nitrite | PVF+/MWCNTs | DPV | 1–400 | 0.1 | Mineral water | [164] |
|
| ||||||
| 4-Nitrophenol | MWCNTs | FI-Amp | 5–300∗ | 1.5∗ | Water | [35] |
|
| ||||||
| 4-Nitrophenol | Cu | Amp | 50–850 | 1.91 | [165] | |
|
| ||||||
| 2-Nitrophenol 4-Nitrophenol |
Bi | DPV | 2–200 4–400 |
5.42 7.48 |
[166] | |
|
| ||||||
| Pantoprazole | PPy-PTZ | Pot | 10–11000 | 6.9 | Pharmaceuticals | [167] |
|
| ||||||
| Paracetamol | MI-PPy | DPV | 5–500 1250–4500 |
0.79 | Pharmaceuticals | [168] |
|
| ||||||
| Phenothiazine | MI-PPy | DPV | 1–300 500–10000 |
0.3 | Model and real biological | [169] |
|
| ||||||
| D-, L- Pyroglutamic acid | MI-poly[5-MTCA–Cu(II)] | DPASV | 2.8–170.0∗ | 0.77∗ | Cerebrospinal fluid, blood plasma, urine | [66] |
|
| ||||||
| Quercetin | p-AMT | DPV | 0.1–6∗∗ | 2.2 | — | [170] |
|
| ||||||
| Ranitidine | Au-NP/MIP-sol–gel/MWCNTs-COOH | SWV | 0.05–2.0 | 0.02 | Human urine | [61] |
|
| ||||||
| Serotonin | p(P3CA) | AdDPSV | 0.01–1.0 | 0.0025 | Blood serum, urine | [171] |
|
| ||||||
| Sildenafil citrate | PPy-citrate | Pot | 34–1700 | 30 | Pharmaceuticals | [172] |
|
| ||||||
| Sulfanilamide | MI-PPy | DPV | 0.05–1.1 1.1–48 |
0.02 | Spiked human serum, ground water | [173] |
|
| ||||||
| Sulfamethoxazole | MI-OxPPy | DPV | 25–750 | 0.359 | Pharmaceuticals | [59] |
|
| ||||||
| Thiocarbohydrazide | MI-PPy | DPV | 500–6000 | 50 | Biological | [174] |
|
| ||||||
| 6-Thioguanine | MI-polyneutral red/ERGO | DPASV | 0.124–78.0∗ | 0.02∗ | Pharmaceuticals, urine, serum | [175] |
|
| ||||||
| Triamterene | MI-PPy/MWCNTs-COOH | DPV | 0.08–265 | 0.00335 | Serum, pharmaceuticals | [176] |
|
| ||||||
| L-Tyrosine | graphene | SWV | 0.8–60 | 0.07 | Urine | [177] |
|
| ||||||
| Uranium(VI) | PPy-ZnUO2(CH3COO)4 | Pot | 1–10000 | 0.63 | Mineral and tap water | [178] |
|
| ||||||
| Uric acid | Ox-PEDOT-nf | DPV | 0.01–20.0 | 0.0013 | Blood serum, urine | [179] |
|
| ||||||
| Valacyclovir | CuMPs | AdSWV | 0.002–0.01 | 0.000178 | Pharmaceuticals | [180] |
|
| ||||||
| Vitamin B12 | PNT | SWV | 0.2–9.5 | 0.093 | Tablets | [181] |
|
| ||||||
| Vitamin B12 | SWCNTs-chitosan | SWV | 0.005–0.1 | 0.00089 | Pharmaceuticals | [182] |
|
| ||||||
| Zinc | Tartrazine-PPy | Pot | 10–100000 | 8 | Barley flakes, rice dry milk | [183] |
∗ng·mL−1; ∗∗µg·mL−1; ET: electrochemically treated; MI: molecularly imprinted; PPy: polypyrrole; FUAA: 5-fluorouracil-N-acetyl acrylamide; NDs: nanodendrites; CNT: carbon nanotubes; ASV: anodic stripping voltammetry; FSA: ferrocene sulfonic acid; PI3AA: poly(indole-3-acetic acid); NAPD: N-acryloyl-pyrrolidine-2,5-dione; NPs: nanoparticles; CHPA: 2-chloro-N-(4-hydroxyphenyl)-acetamide; PVP: polyvinylpyrrolidone; SWAdSV: square wave adsorptive stripping voltammetry; PANI: polyaniline; NRs: nanorodes; MWCNTs: multiwall carbon nanotubes; P4VP: poly(4-vinyl pyridine); poly(4VP-co-Ani): poly(4-vinylpyridine-co-aniline); MIP: molecularly imprinted polymer; PPr: polyproline; chronoamp: chronoamperometry; o-PD: o-phenylenediamine; EIS: electrochemical impedance spectroscopy; OMNiIIP: one monomer ion imprinted polymer; SSA: sulfosalicylic acid; P4R: Ponceau 4R azo dye; PSS-CnP: polystyrene sulfonate-carbon nanopowders; NS: nanostructure; CQDs: carbon quantum dots; NHPM: N-hydroxyphenyl maleimide; LSV: linear sweep voltammetry; Ag@CdSNPs: AgCdS core shell nanoparticles; PVC: poly(vinyl chloride); PEDOT-C14: 3,4-ethylenedioxythiophene; ITSV: ion transfer stripping voltammetry; pTAT: poly(triaminotriazine); DPCSV: differential pulse cathodic stripping voltammetry; OxPPy: overoxidized polypyrrole; NFs-nanofibers; CoPcTS: cobalt(II) phthalocyanine tetrasulfonate; pMAC: poly(N-methacryloyl-L-cysteine); ERGO: electrochemically reduced graphene oxide; pNMGA: poly(N-methacryloyl glutamic acid); QD: quantum dots; CIP: complex imprinted polymer; pAEP: poly[(p-acryloylaminophenyl)-{(4-aminophenyl)-diethyl ammonium}-ethylphosphate]; PB: Prussian Blue; MF: mercury film; SPIONs: superparamagnetic iron oxide nanoparticles; MISP: molecularly imprinted star polymer; Bz: benzidine; PVF: poly(vinylferrocene); PTZ: pantoprazole; MTCA: methyl-2-thiophene carboxylic acid; p-AMT: polymerized 5-amino-2-mercapto-1,3,4-thiadiazole; p(P3CA): poly(pyrrole-3-carboxylic acid); Ox-PEDOT-nf: overoxidized poly (3,4-ethylene-dioxythiophene) nanofibers; CuMPs: copper micropoarticles; PNTs: peptide nanotubes; copper microparticles; SWCNTs: single-wall carbon nanotubes. All the other abbreviations are like those in the previous tables.